These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8557890)

  • 41. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
    J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in platelet monoamine oxidase and plasma dopamine-beta-hydroxylase activities in lithium-treated bipolar patients.
    Sofuoğlu S; Doğan P; Köse K; Eşel E; Baştũrk M; Oğuz H; Gönül AS
    Psychiatry Res; 1995 Nov; 59(1-2):165-70. PubMed ID: 8771233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A; McCue RE; Friedman E; Cooper T
    Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D; Davidson J; Wasik J; Mattox A
    Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response.
    Hitzemann RJ; Sautter F; Hitzemann B; Hirschowitz J; Garver DL
    Psychiatry Res; 1984 Mar; 11(3):211-21. PubMed ID: 6587414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. A preliminary report.
    Leckman JF; Gershon ES; Nichols AS; Murphy DL
    Arch Gen Psychiatry; 1977 May; 34(5):601-6. PubMed ID: 871234
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
    Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Personality traits and monoamine oxidase activity in platelets in depressed patients.
    Perris C; Eisemann M; von Knorring L; Oreland L; Perris H
    Neuropsychobiology; 1984; 12(4):201-5. PubMed ID: 6535064
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased platelet monoamine oxidase activity in affective disorders.
    Reveley MA; Glover V; Sandler M; Coppen A
    Psychopharmacology (Berl); 1981; 73(3):257-60. PubMed ID: 6787645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced platelet MAO activity and vulnerability to psychiatric disorders.
    Pandey GN; Dorus E; Shaughnessy R; Gaviria M; Val E; Davis JM
    Psychiatry Res; 1980 Jul; 2(3):315-21. PubMed ID: 6932071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
    Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
    Poirier MF; Lôo H; Lefur G; Mitrani N
    Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelet monoamine oxidase (MAO) activity and genetic vulnerability to bipolar (BP) affective illness.
    Gershon ES; Targum SD; Leckman JF
    Psychopharmacol Bull; 1979 Jan; 15(1):27-30. PubMed ID: 419242
    [No Abstract]   [Full Text] [Related]  

  • 56. Elevated platelet monoamine oxidase activity in patients wth nonendogenous depression.
    White K; Shih J; Fong T; Young H; Gelfand R; Boyd J; Simpson G; Sloane RB
    Am J Psychiatry; 1980 Oct; 137(10):1258-9. PubMed ID: 7416279
    [No Abstract]   [Full Text] [Related]  

  • 57. Platelet MAO activity in geriatric patients with depression and dementia.
    Alexopoulos GS; Young RC; Lieberman KW; Shamoian CA
    Am J Psychiatry; 1987 Nov; 144(11):1480-3. PubMed ID: 3674232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parents of high risk subjects defined by levels of monoamine oxidase activity.
    Puchall LB; Coursey RD; Buchsbaum MS; Murphy DL
    Schizophr Bull; 1980; 6(2):338-46. PubMed ID: 7375867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Platelet monoamine oxidase activity and clomipramine-induced mania in unipolar depressed patients.
    van Kammen DP; van Scheyen JD; Murphy DL
    Biol Psychiatry; 1980 Aug; 15(4):565-73. PubMed ID: 7397287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.